U.S. Entertainment Stock News

Terns Pharmaceuticals (TERN) is turning heads after sharing new results from its CARDINAL trial on TERN-701, a treatment aimed at chronic myeloid leukemia. The data was selected for oral presentation at the upcoming ASH Annual Meeting and has sparked fresh interest in the company’s pipeline. See our latest analysis for Terns Pharmaceuticals. With momentum building around positive data from the CARDINAL trial and a spotlight on Terns at both the ASH conference and major investor events, the...

ONE Gas (OGS) has shown steady performance over recent months, with investors watching for further signs of momentum. The stock’s return year to date sits at around 19%, offering a point for comparison with sector peers. See our latest analysis for ONE Gas. ONE Gas has enjoyed a robust 18.6% year-to-date share price return, with the latest uptick partly reflecting investors’ constructive outlook on its steady fundamentals and recent gains. Momentum has generally built through 2024, leaving...

ClearBridge Growth Strategy recently highlighted XPO, Inc. as the fourth-largest less-than-truckload (LTL) provider in North America, noting its progress under new leadership with deep industry expertise to improve service levels and drive operational improvements. An important insight was the focus on margin expansion and service enhancement initiatives, which aim to better position XPO against competitors even if freight demand remains subdued. To better understand how XPO's operational...

Earlier this month, Paychex reported quarterly earnings that surpassed expectations and raised its full-year adjusted EPS growth guidance, while highlighting strong client retention and momentum in HR technology investments. This update sheds light on renewed analyst optimism about Paychex's outlook, particularly as the company evolves its service offerings amid recent stock underperformance. We’ll explore how Paychex’s increased earnings guidance and emphasis on client retention shape its...

Solventum Corporation recently reported its third quarter 2025 results, with revenue of US$2.10 billion and net income jumping to a very large increase from a year ago, as well as raising full-year earnings guidance to the high end of its previously indicated range. Management emphasized that accelerated volume improvements across segments and faster-than-expected benefits from commercial and product innovation initiatives played a key role in these results. We’ll assess how the company's...

Tetra Tech (TTEK) shares have been quietly trending upward over the month, with a gain of 11%. Despite some softness in annual revenue growth, the company’s solid net income growth may have investors taking a closer look. See our latest analysis for Tetra Tech. Momentum has picked up for Tetra Tech recently, with the stock’s 1-month share price return at a strong 11.4%, even after a brief dip today. Looking at the bigger picture, however, total shareholder return for the past year is still...

Kimbell Royalty Partners, LP recently reported third-quarter 2025 results, including revenue of US$80.62 million, net income of US$19.68 million, and an average daily production of 25,530 Boe, with distributions reduced to US$0.35 per common unit as 25% of distributable cash was allocated to debt reduction. This shift in dividend policy, combined with lower earnings and revenue compared to the prior year, suggests a focus on strengthening the balance sheet amid changing industry...

Earlier in November 2025, United Natural Foods reported that its natural and organic business continues to grow strongly on the back of robust consumer demand, with management signaling expectations for low single-digit annual net sales growth from fiscal 2024 through 2027. Ahead-of-plan progress on the company’s multi-year financial roadmap, combined with disciplined cost management and portfolio updates, highlights its adaptability amid industry challenges such as inflation and weakened...

On November 12, 2025, Travel + Leisure Co. declared a quarterly cash dividend of US$0.56 per share, payable on December 31, 2025, to shareholders of record as of December 12, 2025, and published updated investor presentation materials emphasizing transparency and regular communication. Investor confidence has been further supported by the company’s strong third-quarter results, new institutional investment, and the continuation of its dividend policy, even as an officer sold shares during...

ePlus announced strong financial results for the quarter and six months ended September 30, 2025, with revenue rising to US$608.83 million for the quarter and net income reaching US$34.86 million, accompanied by a quarterly dividend declaration of US$0.25 per share. The company also raised its fiscal year 2026 guidance, expecting mid-teens growth in net sales and gross profit, along with a higher increase in adjusted EBITDA, reflecting ongoing operational momentum. We'll assess how ePlus's...

Polaris (PII) shares have seen shifts over the past month, with a modest drop despite a strong rebound over the past 3 months. Investors are now looking at factors that could drive the next move. See our latest analysis for Polaris. Polaris has posted a steady 14% year-to-date share price gain and notched a solid 90-day share price return of 12.6%, signaling building momentum even as the latest month cooled slightly. Long-term, though, total shareholder returns have lagged, highlighting a gap...

Sun Communities (NYSE:SUI) caught investor attention after posting Q3 2025 results that beat guidance for core Funds from Operations per share. A wave of analyst upgrades followed as confidence in its core business segments gained traction. See our latest analysis for Sun Communities. The upbeat Q3 results are just the latest in a year marked by significant developments for Sun Communities, including the sale of its marina business, new strategic partnerships, and a CEO transition. With a...

Wondering if Amgen is a bargain right now? You are not alone. Investors are constantly on the lookout for stocks whose price might not reflect their true worth. The stock has been on quite a run, climbing 5.2% over the past week, 13.3% for the past month, and up an impressive 29.9% year-to-date. Amgen's recent gains have coincided with industry optimism around its new drug approvals and ongoing research partnerships, which have been widely discussed in news coverage. In addition, analyst...

U.S. Bancorp recently launched the U.S. Bank Split™ World Mastercard, which offers automatic, interest-free installment payments on every purchase, while also rolling out a suite of co-branded checking and credit cards in partnership with Edward Jones, now available to Edward Jones’ 9 million clients through a network of more than 20,000 financial advisors. These developments open up new avenues for U.S. Bancorp to reach a wider customer base and streamline how consumers manage payments and...

Sally Beauty Holdings recently reported fiscal fourth quarter and full-year 2025 results, showing net sales of US$3.70 billion and a year-over-year increase in net income and earnings per share, alongside new guidance for steady performance in 2026. A key insight from the announcement is the company's continued investment in digital growth, exclusive brands, and store refresh initiatives, supported by a sizable ongoing share buyback program that has now reduced shares outstanding by over 32%...

Amkor Technology (AMKR) stock is drawing some fresh attention as investors revisit the company’s performance over the past few months. With the stock up 33% in the past 3 months, there is growing curiosity about what might be driving renewed interest. See our latest analysis for Amkor Technology. Momentum is clearly building for Amkor Technology, with the past 90 days seeing a sharp 33% share price return that stands out from a more modest 1-year total shareholder return of nearly 30%. The...

Pfizer (PFE) has been a topic of interest for investors, especially as its stock returned nearly 3% over the past month. Despite some ups and downs this year, the company’s recent performance offers some intriguing signals for those watching the pharmaceutical sector closely. See our latest analysis for Pfizer. Pfizer’s recent 2.75% 1-month share price return hints at shifting sentiment after a stretch of muted performance, following headline-making events such as new product launches and...

Royalty Pharma (RPRX) grabbed investor attention after releasing an improved full-year 2025 outlook, which highlights stronger expected growth. Third quarter results showed higher revenue and continued share buybacks, signaling management’s confidence and a focus on shareholder returns. See our latest analysis for Royalty Pharma. Following these updates, Royalty Pharma’s share price has posted an impressive 51.8% gain since the start of the year, as investors responded to renewed growth...

LiveWire Group, Inc. recently released its third-quarter 2025 results, reporting sales of US$5.7 million and a net loss of US$19.4 million, alongside a revision to its full-year operating loss guidance to US$72 million–US$77 million. This update highlights the company’s ongoing improvements in operating efficiency and sales, paired with continued investment in new product development and market expansion. We'll explore how LiveWire's focus on innovative electric vehicles amid near-term...

Commercial Metals (CMC) shares have hovered in a tight range lately, catching the eye of investors who track the broader steel and materials sector. The company’s recent performance provides some interesting context for those considering exposure to cyclical industries. See our latest analysis for Commercial Metals. CMC’s share price momentum has been solid this year, with a 20% year-to-date gain reflecting improved optimism around construction demand and resilient earnings. However, the...

UnitedHealth Group (UNH) shares have caught the attention of investors this week as the stock continues to navigate an uneven stretch. The company saw a slight dip of 3% over the past month, raising questions about what might come next. See our latest analysis for UnitedHealth Group. UnitedHealth Group’s 1-year total shareholder return has slumped by 44.5%, with the share price sitting at $321.86 as of the latest close. While the last quarter’s 5.9% share price rebound hints at stabilizing...

Wondering if Teradyne is a real bargain or just getting swept up in the market buzz? You are in the right place for a clear look at what the numbers say about its true value. Teradyne’s stock has climbed an impressive 34.3% year-to-date, with a remarkable 66.5% gain over the last 12 months. However, it dipped 6.8% in the past week after a standout 20.5% jump during the past month. Recent headlines have highlighted industry-wide optimism around automation and semiconductor testing, which sent...

Absci (ABSI) has caught attention following its latest quarterly earnings release and a strategic update outlining a focus on ABS-201. New clinical trials are set, and the company is taking active steps to seek external partners for ABS-101. See our latest analysis for Absci. Absci’s recent earnings report and strategic update turned heads, but the share price has been volatile. After a dramatic 1-month share price drop of 43.6%, sentiment rebounded with a one-day lift of 6.8%. While...

U-Haul Holding Company recently reported its second quarter and six-month earnings for 2025, showing higher revenue of US$1.72 billion for the quarter and US$3.35 billion for the six months but a significant decline in net income compared to the prior year. Alongside these results, U-Haul closed its long-operating Little Rock repair shop while opening a new, larger facility in North Little Rock, signaling a shift in regional operations and workforce allocation. With net income declining...